IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19

Autoimmun Rev. 2021 Nov;20(11):102951. doi: 10.1016/j.autrev.2021.102951. Epub 2021 Sep 9.

Authors

Laure Badier¹, Albanie Toledano², Tiphaine Porel², Sylvain Dumond³, Julien Jouglen³, Laurent Sailler², Haleh Bagheri¹, Guillaume Moulis², Margaux Lafaurie⁴

Affiliations

¹ Pharmacovigilance Center, Department of Clinical Pharmacology, Toulouse University Hospital, France.
² Department of Internal Medicine, Toulouse University hospital, France.
³ Department of Pharmacy, Toulouse University Hospital, France.
⁴ Pharmacovigilance Center, Department of Clinical Pharmacology, Toulouse University Hospital, France. Electronic address: margaux.lafaurie@univ-tlse3.fr.

No abstract available

Publication types

Letter

MeSH terms

Adult
COVID-19 Vaccines
COVID-19*
ChAdOx1 nCoV-19
Humans
Immunoglobulin A
Vaccination
Vasculitis*

Substances

COVID-19 Vaccines
Immunoglobulin A
ChAdOx1 nCoV-19